$ADVM Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Adverum Biotechnologies, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Adverum Biotechnologies, Inc.. Get notifications about new insider transactions in Adverum Biotechnologies, Inc. for free.

Page: < prev 1 2 3 4 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 13 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Option Exercise	M	3.15	285	898	236,500
May 13 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Sell	S	34.94	285	9,959	9,000	9.3 K to 9 K (-3.07 %)
May 13 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Buy	M	3.15	285	898	9,285	9 K to 9.3 K (+3.17 %)
May 12 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	34.29	132	4,527	43,121	43.3 K to 43.1 K (-0.31 %)
May 12 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	33.70	552	18,604	43,253	43.8 K to 43.3 K (-1.26 %)
May 12 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	32.80	508	16,662	43,805	44.3 K to 43.8 K (-1.15 %)
May 12 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Option Exercise	M	3.15	715	2,252	236,785
May 12 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Sell	S	34.91	715	24,964	9,000	9.7 K to 9 K (-7.36 %)
May 12 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Buy	M	3.15	715	2,252	9,715	9 K to 9.7 K (+7.94 %)
May 12 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	34.91	1,785	62,323	576,204	578 K to 576.2 K (-0.31 %)
May 11 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	33.05	17,250	570,092	418,931	436.2 K to 418.9 K (-3.95 %)
May 08 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	500	1,375	97,500
May 08 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	33.28	500	16,638	7,000	7.5 K to 7 K (-6.67 %)
May 08 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	500	1,375	7,500	7 K to 7.5 K (+7.14 %)
May 07 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Sell	S	30.00	25,000	750,093	283,988	309 K to 284 K (-8.09 %)
May 06 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Option Exercise	M	0.19	5,000	950	22,500
May 06 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Sell	S	30.87	5,000	154,349	11,320	16.3 K to 11.3 K (-30.64 %)
May 06 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Buy	M	0.19	5,000	950	16,320	11.3 K to 16.3 K (+44.17 %)
May 06 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Option Exercise	M	3.15	2,500	7,875	237,500
May 06 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Sell	S	31.59	2,500	78,972	9,000	11.5 K to 9 K (-21.74 %)
May 06 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Buy	M	3.15	2,500	7,875	11,500	9 K to 11.5 K (+27.78 %)
May 06 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	30.87	1,192	36,797	44,313	45.5 K to 44.3 K (-2.62 %)
May 05 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	32.37	20,000	647,306	577,989	598 K to 578 K (-3.34 %)
Apr 30 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	1,000	2,750	98,000
Apr 30 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	35.67	1,000	35,667	7,000	8 K to 7 K (-12.50 %)
Apr 30 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	1,000	2,750	8,000	7 K to 8 K (+14.29 %)
Apr 29 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	35.61	1,192	42,443	45,505	46.7 K to 45.5 K (-2.55 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	38.62	16,875	651,665	436,181	453.1 K to 436.2 K (-3.72 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Option Exercise	A	39.35	7,000	275,450	7,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Grant	A	0.00	2,000	0	2,000	0 to 2 K
Apr 23 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Option Exercise	A	39.35	7,000	275,450	7,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Grant	A	0.00	2,000	0	453,056	451.1 K to 453.1 K (+0.44 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Rubio Roman G.	SVP, Translational ...	Option Exercise	A	39.35	20,000	787,000	20,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Rubio Roman G.	SVP, Translational ...	Grant	A	0.00	7,000	0	7,000	0 to 7 K
Apr 23 2015	AAVL	Adverum Biotechnol ...	MCLAUGHLIN JOHN PETER	Director	Option Exercise	A	39.35	7,000	275,450	7,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	MCLAUGHLIN JOHN PETER	Director	Grant	A	0.00	2,000	0	2,000	0 to 2 K
Apr 23 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Option Exercise	A	39.35	23,000	905,050	23,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Grant	A	0.00	8,000	0	11,320	3.3 K to 11.3 K (+240.96 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	A	39.35	20,000	787,000	20,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	1,000	2,750	99,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Grant	A	0.00	7,000	0	7,000	0 to 7 K
Apr 23 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	39.21	1,000	39,211	0	1,000 to 0 (-100.00 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	1,000	2,750	1,000	0 to 1,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Option Exercise	A	39.35	67,000	2,636,450	67,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Grant	A	0.00	23,000	0	308,988	286 K to 309 K (+8.04 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	A	39.35	7,000	275,450	7,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Grant	A	0.00	2,000	0	597,989	596 K to 598 K (+0.34 %)
Apr 23 2015	AAVL	Adverum Biotechnol ...	Barone Samuel B.	Chief Medical Offic ...	Option Exercise	A	39.35	20,000	787,000	20,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Barone Samuel B.	Chief Medical Offic ...	Grant	A	0.00	7,000	0	7,000	0 to 7 K
Apr 23 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Option Exercise	A	39.35	25,000	983,750	25,000
Apr 23 2015	AAVL	Adverum Biotechnol ...	Bain Linda	Chief Financial Off ...	Grant	A	0.00	9,000	0	9,000	0 to 9 K
Apr 21 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	40.19	1,192	47,910	46,697	47.9 K to 46.7 K (-2.49 %)
Apr 20 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	42.04	200	8,408	595,989	596.2 K to 596 K (-0.03 %)
Apr 20 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	41.59	24,800	1,031,345	596,189	621 K to 596.2 K (-3.99 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Sell	S	39.93	4,600	183,663	2,438,176	2.4 M to 2.4 M (-0.19 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Sell	S	40.69	776	31,579	2,442,776	2.4 M to 2.4 M (-0.03 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Sell	S	39.94	7,350	293,587	2,443,552	2.5 M to 2.4 M (-0.30 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Sell	S	39.09	12,274	479,843	2,450,902	2.5 M to 2.5 M (-0.50 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	40.74	24	978	47,889	47.9 K to 47.9 K (-0.05 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	39.85	338	13,468	47,913	48.3 K to 47.9 K (-0.70 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	39.10	830	32,450	48,251	49.1 K to 48.3 K (-1.69 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	1,000	2,750	100,000
Apr 15 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	39.45	1,000	39,448	0	1,000 to 0 (-100.00 %)
Apr 15 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	1,000	2,750	1,000	0 to 1,000
Apr 13 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	40.38	200	8,076	451,056	451.3 K to 451.1 K (-0.04 %)
Apr 13 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	39.72	17,050	677,202	451,256	468.3 K to 451.3 K (-3.64 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.06	32	1,250	11,531	11.6 K to 11.5 K (-0.28 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	38.59	968	37,353	11,563	12.5 K to 11.6 K (-7.72 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.06	32	1,250	11,531	11.6 K to 11.5 K (-0.28 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	38.59	968	37,353	11,563	12.5 K to 11.6 K (-7.72 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.06	32	1,250	11,531	11.6 K to 11.5 K (-0.28 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	38.59	968	37,353	11,563	12.5 K to 11.6 K (-7.72 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.94	2,500	99,841	620,989	623.5 K to 621 K (-0.40 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	39.06	726	28,358	623,489	624.2 K to 623.5 K (-0.12 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	38.59	21,774	840,202	624,215	646 K to 624.2 K (-3.37 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Option Exercise	M	0.19	27,500	5,225	27,500
Apr 08 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Sell	S	39.06	887	34,646	3,320	4.2 K to 3.3 K (-21.08 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Sell	S	38.59	26,613	1,026,926	4,207	30.8 K to 4.2 K (-86.35 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Business Opera ...	Buy	M	0.19	27,500	5,225	30,820	3.3 K to 30.8 K (+828.31 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Option Exercise	M	2.75	9,000	24,750	101,000
Apr 08 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	39.06	292	11,406	0	292 to 0 (-100.00 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Sell	S	38.59	8,708	336,019	292	9 K to 292 (-96.76 %)
Apr 08 2015	AAVL	Adverum Biotechnol ...	Gasmi Mehdi	VP, Pharmaceutical ...	Buy	M	2.75	9,000	24,750	9,000	0 to 9 K
Jan 15 2015	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Sell	S	55.46	100,000	5,546,000	2,463,176	2.6 M to 2.5 M (-3.90 %)
Jan 15 2015	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Sell	S	55.46	14,000	776,440	49,081	63.1 K to 49.1 K (-22.19 %)
Jan 15 2015	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Sell	S	55.46	91,000	5,046,860	468,306	559.3 K to 468.3 K (-16.27 %)
Jan 15 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Sell	S	55.46	85,000	4,714,100	285,988	371 K to 286 K (-22.91 %)
Jan 15 2015	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Sell	S	55.46	100,000	5,546,000	645,989	746 K to 646 K (-13.41 %)
Jan 14 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Option Exercise	M	0.21	413	87	159,587
Jan 14 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Gift	G	0.00	413	0	413	0 to 413
Jan 14 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Gift	G	0.00	413	0	370,988	371.4 K to 371 K (-0.11 %)
Jan 14 2015	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Buy	M	0.21	413	87	371,401	371 K to 371.4 K (+0.11 %)
Nov 14 2014	AAVL	Adverum Biotechnol ...	Rubio Roman G.	SVP, Translational ...	Option Exercise	A	33.70	180,000	6,066,000	180,000
Aug 07 2014	AAVL	Adverum Biotechnol ...	Venrock Healthcare Capital Par ...	10% Owner	Option Exercise	C	0.00	1,965,471	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Venrock Healthcare Capital Par ...	10% Owner	Buy	P	17.00	400,000	6,800,000	2,365,471	2 M to 2.4 M (+20.35 %)
Aug 07 2014	AAVL	Adverum Biotechnol ...	Venrock Healthcare Capital Par ...	10% Owner	Buy	C	0.00	1,965,471	0	1,965,471	0 to 2 M
Aug 07 2014	AAVL	Adverum Biotechnol ...	Venrock Associates VI, L.P.	10% Owner	Option Exercise	C	0.00	1,965,471	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Venrock Associates VI, L.P.	10% Owner	Buy	P	17.00	400,000	6,800,000	2,365,471	2 M to 2.4 M (+20.35 %)
Aug 07 2014	AAVL	Adverum Biotechnol ...	Venrock Associates VI, L.P.	10% Owner	Buy	C	0.00	1,965,471	0	1,965,471	0 to 2 M
Aug 07 2014	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Option Exercise	C	0.00	295,115	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Option Exercise	C	0.00	2,799,269	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Buy	C	0.00	295,115	0	3,094,384	2.8 M to 3.1 M (+10.54 %)
Aug 07 2014	AAVL	Adverum Biotechnol ...	Zygtech, LLC	10% Owner	Buy	C	0.00	2,799,269	0	2,799,269	0 to 2.8 M
Aug 07 2014	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Option Exercise	C	0.00	63,081	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Wachter Paul	Director	Buy	C	0.00	63,081	0	63,081	0 to 63.1 K
Aug 07 2014	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Option Exercise	C	0.00	25,306	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Option Exercise	X	0.00	6,620	0	25,306
Aug 07 2014	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Option Exercise	X	1.45	6,620	9,599	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Option Exercise	X	0.15	34,000	5,100	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Buy	C	0.00	25,306	0	559,306	534 K to 559.3 K (+4.74 %)
Aug 07 2014	AAVL	Adverum Biotechnol ...	Schwartz Steven Daniel	Director	Buy	X	0.15	34,000	5,100	534,000	500 K to 534 K (+6.80 %)
Aug 07 2014	AAVL	Adverum Biotechnol ...	MCLAUGHLIN JOHN PETER	Director	Option Exercise	C	0.00	13,280	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	MCLAUGHLIN JOHN PETER	Director	Option Exercise	C	0.00	13,280	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	MCLAUGHLIN JOHN PETER	Director	Buy	C	0.00	13,280	0	13,280	0 to 13.3 K
Aug 07 2014	AAVL	Adverum Biotechnol ...	MCLAUGHLIN JOHN PETER	Director	Buy	C	0.00	13,280	0	13,280	0 to 13.3 K
Aug 07 2014	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Legal and Corp ...	Option Exercise	C	0.00	3,320	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Hull Hans	SVP, Legal and Corp ...	Buy	C	0.00	3,320	0	3,320	0 to 3.3 K
Aug 07 2014	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Option Exercise	C	0.00	10,988	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Option Exercise	X	0.00	3,102	0	10,988
Aug 07 2014	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Option Exercise	X	1.45	3,102	4,498	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Chalberg Thomas W.	Chief Executive Off ...	Buy	C	0.00	10,988	0	370,988	360 K to 371 K (+3.05 %)
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	C	0.00	12,531	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	X	0.00	4,137	0	12,531
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	X	1.45	4,137	5,999	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	C	0.00	12,531	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	X	0.00	4,137	0	12,531
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	X	1.45	4,137	5,999	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	C	0.00	12,531	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	X	0.00	4,137	0	12,531
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	X	1.45	4,137	5,999	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	C	0.00	20,989	0	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	X	0.00	5,689	0	20,989
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	X	1.45	5,689	8,249	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Option Exercise	X	0.15	25,000	3,750	0
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Buy	C	0.00	12,531	0	12,531	0 to 12.5 K
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Buy	C	0.00	12,531	0	12,531	0 to 12.5 K
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Buy	C	0.00	12,531	0	12,531	0 to 12.5 K
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Buy	C	0.00	20,989	0	745,989	725 K to 746 K (+2.90 %)
Aug 07 2014	AAVL	Adverum Biotechnol ...	Blumenkranz Mark S.	Director	Buy	X	0.15	25,000	3,750	725,000	700 K to 725 K (+3.57 %)
Aug 05 2014	AAVL	Adverum Biotechnol ...	REGENERON PHARMACEUTICALS INC	10% Owner	Option Exercise	C	0.00	531,208	0	0
Aug 05 2014	AAVL	Adverum Biotechnol ...	REGENERON PHARMACEUTICALS INC	10% Owner	Option Exercise	C	0.00	689,655	0	0
Aug 05 2014	AAVL	Adverum Biotechnol ...	REGENERON PHARMACEUTICALS INC	10% Owner	Buy	P	17.00	588,235	9,999,995	1,809,098	1.2 M to 1.8 M (+48.18 %)
Aug 05 2014	AAVL	Adverum Biotechnol ...	REGENERON PHARMACEUTICALS INC	10% Owner	Buy	C	0.00	531,208	0	1,220,863	689.7 K to 1.2 M (+77.03 %)
Aug 05 2014	AAVL	Adverum Biotechnol ...	REGENERON PHARMACEUTICALS INC	10% Owner	Buy	C	0.00	689,655	0	689,655	0 to 689.7 K
Aug 05 2014	AAVL	Adverum Biotechnol ...	Flynn James E	10% Owner	Option Exercise	C	0.00	531,208	0	0
Aug 05 2014	AAVL	Adverum Biotechnol ...	Flynn James E	10% Owner	Option Exercise	C	0.00	147,410	0	0
Aug 05 2014	AAVL	Adverum Biotechnol ...	Flynn James E	10% Owner	Option Exercise	C	0.00	184,594	0	0
Aug 05 2014	AAVL	Adverum Biotechnol ...	Flynn James E	10% Owner	Buy	P	24.57	31,650	777,641	627,267	595.6 K to 627.3 K (+5.31 %)
Aug 05 2014	AAVL	Adverum Biotechnol ...	Flynn James E	10% Owner	Buy	P	26.35	49,981	1,316,999	595,617	545.6 K to 595.6 K (+9.16 %)
Aug 05 2014	AAVL	Adverum Biotechnol ...	Flynn James E	10% Owner	Buy	P	26.14	27,600	721,464	545,636	518 K to 545.6 K (+5.33 %)

Page: < prev 1 2 3 4 next >